NorthWest Biotherapeutics Inc (NWBO)

[XMaster2023]

For the record;
On June 4, 2024, Northwest Biotherapeutics, Inc. (the “Company”) entered into a Stock Purchase Agreement (SPA) with SIO Capital Management LLC, for SIO's purchase of eight million, one hundred twenty-five thousand (8,125,000) shares of the Company's common stock at forty cents ($0.40) per share based on certain terms initially negotiated on May 31, 2024. The transaction is expected to close on June 5, 2024. The gross proceeds will be $3,250,000. The funds will be used for the Company’s ongoing business operations. Joseph Gunnar & Co., LLC acted as placement agent.
Because they needed $3,250,000.